Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mycn protein, human (compound)
Most Correlated Studies
- Neuroblastoma cell lines treated with THZ1, actinomycin D, MYCN shRNA, or MYCN-overexpression
- Neuroblastoma SHEP cells with dox-induced/uninduced MYCN before or after nutlin-3a treatment
- Neuroblastoma bone marrow metastasis SK-N-BE(2) cells with MYCN or TEAD4 shRNA knockdown
- Neuroblastoma of brain cell lines compared based on MYCN-amplification status
- Neuroblastoma SH-EP-21N and BE(2) cells with conditional MYCN and TWIST1 gene silencing
Most Relevant Literature
- A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an …
- Integrating multi-omics data reveals neuroblastoma subtypes in the tumor microenvironment.
- MYCN amplification in spinal ependymoma: A five-year retrospective study.
- RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
- Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?
Most Relevant Clinical Trials
- Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
- Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
- PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
- SF1126 for Patients With Relapsed or Refractory Neuroblastoma
- Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With M…
